Aspirin/Phosphatidylcholine

阿司匹林/卵磷脂

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Phosphatidylcholine
Drug Alias Name卵磷脂阿司匹林Aspirin-PC阿司匹林卵磷脂Phosphatidylcholine/Aspirin乙酰水杨酸卵磷脂 +[15] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainFeverMyocardial Infarction +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Aspirin
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPlx Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPlx Pharma Inc
Active IndicationsN/A
Inactive IndicationsPainFeverMyocardial Infarction +[4] 

Other Information

ATC CodeN/A
Related LinksN/A